Authors:
Storms, W
Michele, TM
Knorr, B
Noonan, G
Shapiro, G
Zhang, J
Shingo, S
Reiss, TF
Citation: W. Storms et al., Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged >= 6 years, CLIN EXP AL, 31(1), 2001, pp. 77-87
Authors:
Busse, W
Wolfe, J
Storms, W
Srebro, S
Edwards, L
Johnson, M
Bowers, BW
Rogenes, PR
Rickard, K
Citation: W. Busse et al., Fluticasone propionate compared with zafirlukast in controlling persistentasthma - A randomized double-blind, placebo-controlled trial, J FAM PRACT, 50(7), 2001, pp. 595-602
Authors:
Dockhorn, R
Aaronson, D
Bronsky, E
Chervinsky, P
Cohen, R
Ehtessabian, R
Finn, A
Grossman, J
Howland, W
Kaiser, H
Pearlman, D
Sublett, J
Ratner, P
Settipane, G
Sim, T
Storms, W
Webb, R
Drda, K
Wood, C
Citation: R. Dockhorn et al., Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray aloneand in combination for the treatment of rhinorrhea in perennial rhinitis, ANN ALLER A, 82(4), 1999, pp. 349-359
Authors:
Sorkness, CA
LaForce, C
Storms, W
Lincourt, WR
Edwards, L
Rogenes, PR
Citation: Ca. Sorkness et al., Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma, CLIN THER, 21(2), 1999, pp. 353-367
Citation: W. Storms, Double-blind, placebo-controlled study of single doses of chlorofluorocarbon (CFC) and CFC-free cromolyn sodium for exercise-induced bronchoconstriction, CURR THER R, 60(12), 1999, pp. 629-637